DE HB302 | 2023-2024 | 152nd General Assembly
Status
Spectrum: Strong Partisan Bill (Democrat 16-1)
Status: Enrolled on June 20 2024 - 75% progression
Action: 2024-06-20 - Passed By Senate. Votes: 18 YES 3 ABSENT
Text: Latest bill text (Draft #2) [HTML]
Status: Enrolled on June 20 2024 - 75% progression
Action: 2024-06-20 - Passed By Senate. Votes: 18 YES 3 ABSENT
Text: Latest bill text (Draft #2) [HTML]
Summary
According to the American Cancer Society, prostate cancer is the second-leading cause of death from cancer in men. It is estimated that about 1 in 41 men will die of prostate cancer. According to ZERO Prostate Cancer, Black men face serious health care disparities regarding prostate cancer. 1 in 6 Black men will develop prostate cancer in their lifetime compared to 1 in 8 men overall. Black men are also 1.7 times more likely to be diagnosed with, and 2.1 times more likely to die from, prostate cancer than white men.
Title
An Act To Amend Title 18 Of The Delaware Code Relating To Prostate Cancer Screening.
Sponsors
Roll Calls
2024-06-20 - Senate - Senate Third Reading (Y: 18 N: 0 NV: 0 Abs: 3) [PASS]
2024-05-07 - House - House Third Reading (Y: 24 N: 3 NV: 8 Abs: 6) [PASS]
2024-05-07 - House - House Third Reading (Y: 24 N: 3 NV: 8 Abs: 6) [PASS]
History
Date | Chamber | Action |
---|---|---|
2024-06-20 | Passed By Senate. Votes: 18 YES 3 ABSENT | |
2024-05-22 | Reported Out of Committee (Banking, Business, Insurance & Technology) in Senate with 6 On Its Merits | |
2024-05-07 | Assigned to Banking, Business, Insurance & Technology Committee in Senate | |
2024-05-07 | Passed By House. Votes: 24 YES 3 NO 8 NOT VOTING 6 ABSENT | |
2024-04-11 | was introduced and adopted in lieu of HB 302 |